SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 2.305+9.2%Nov 21 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (519)11/12/1998 7:38:00 AM
From: TheSlowLane  Read Replies (1) of 2539
 
Considering the size of the trial, the lack of significant side effects, the overwhelming pent-up consumer demand, and the growing media hype - I think the FDA would have to have very substantial reasons for NOT approving Celebrex. For instance, if half of those 10,000 trial participants were to prematurely expire next week, that would probably slow things down. Otherwise, I believe we'll be good to go. Will be interesting to see how it is received today.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News